Market Cap 39.80M
Revenue (ttm) 40.93M
Net Income (ttm) -15.57M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -38.04%
Debt to Equity Ratio 1.21
Volume 399,000
Avg Vol 886,172
Day's Range N/A - N/A
Shares Out 38.64M
Stochastic %K 10%
Beta 1.47
Analysts Strong Sell
Price Target $4.42

Company Profile

Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, Germany, and internationally. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living. It also provides MyoPro 2 that includes control technology, configuration software and user interfac...

Industry: Medical Devices
Sector: Healthcare
Phone: 617 996 9058
Website: myomo.com
Address:
45 Blue Sky Dr., Suite 101, Burlington, United States
2TrustHim
2TrustHim Jul. 4 at 2:15 PM
$MYO https://www.facebook.com/share/r/18nccoZfLV/?mibextid=wwXIfr
0 · Reply
R0tt3n
R0tt3n Jul. 4 at 4:41 AM
$MYO So, let me get this straight. He told you all to sell myo at .64 and buy Viking pharma at 34 bucks. Eventually Viking after dipping finally went to 39 bucks. Myo went to 1.54. And he’s claiming to have given sound advice like some genius? This is the height of idiocy. The math isn’t mathing with this guy.
0 · Reply
R0tt3n
R0tt3n Jul. 4 at 4:38 AM
$MYO that’s our resident Barry for ya.
0 · Reply
R0tt3n
R0tt3n Jul. 4 at 4:38 AM
$MYO fake n shake of the loose hands with coverage.
0 · Reply
jadeite_haystack
jadeite_haystack Jul. 2 at 8:58 PM
$MYO fake out then breakout. Back above $1.40
0 · Reply
iAccess_Alpha
iAccess_Alpha Jul. 2 at 3:52 PM
Missed it live? Access the $MYO presentation replay here: https://www.webcaster5.com/Webcast/Page/3165/54053 #microcap #smallcap #investing
0 · Reply
MultiversalTruth
MultiversalTruth Jul. 2 at 3:14 PM
$MYO AI QTRLY ANALYSIS - Updated Valuation Scenarios [Update your bull, base, and bear valuation scenarios and estimate: • Fair value • 12-month price target • Expected 52-week high • Expected 52-week low • Probability assigned to each scenario Tell me whether your conviction has increased, decreased, or stayed the same since the previous quarter, and explain why.] Bull Prob 30% Fair Val $9.50 Target $10–11 52H $12 52L $5.50 Base Prob 50% Fair Val $6.75 Target $7–8 52H $9 52L $4.50 Bear Prob 20% Fair Val $3.50 Target $3–4 52H $5 52L $2.25 Rationale The base case assumes: continued modest revenue growth,gross margins near 68%,improving operating leverage,and no significant equity dilution. The bull case depends on accelerating adoption through MyoConnect and stronger-than-expected reimbursement-driven growth leading toward sustained profitability.
1 · Reply
kurtb1969
kurtb1969 Jul. 2 at 1:33 PM
$MYO 970k shares now available for shorting, highest since October last year. Despite the negativity shorts are covering like crazy.
1 · Reply
kurtb1969
kurtb1969 Jul. 1 at 1:55 PM
$MYO massive short covering 777k shares available for shorting on IBKR by far the most available in over a month.
1 · Reply
Jedkra
Jedkra Jun. 30 at 7:39 PM
$MYO OmniHi5 is not a direct MyoPro replacement. It’s mainly a rehab/FES device, while MyoPro is a powered compensatory orthosis for daily use. Different category. Real competitors are more like HKK or Vincent, but Myomo still seems ahead in U.S. reimbursement and commercialization with HCPCS L8701/L8702 and Medicare reimbursement. MyoPro has real weaknesses: weight, comfort and patient selection. But saying it causes shoulder surgeries needs evidence, not just a bearish claim. Competition is real, but OmniHi5 is not the “MyoPro killer.” MYO’s bigger risks are execution, payer friction, cash burn and dilution.
1 · Reply
Latest News on MYO
Myomo Slides: Investor presentation

Jun 23, 2026, 7:00 AM EDT - 11 days ago

Myomo Slides: Investor presentation


Myomo Transcript: Sidoti Micro-Cap Virtual Conference

May 21, 2026, 1:45 PM EDT - 6 weeks ago

Myomo Transcript: Sidoti Micro-Cap Virtual Conference


Myomo Transcript: A.G.P.'s Annual Virtual Healthcare Conference

May 20, 2026, 11:20 AM EDT - 6 weeks ago

Myomo Transcript: A.G.P.'s Annual Virtual Healthcare Conference


Myomo Slides: Investor presentation

May 20, 2026, 7:00 AM EDT - 6 weeks ago

Myomo Slides: Investor presentation


Myomo Announces Participation in Upcoming Investor Conferences

May 14, 2026, 4:05 PM EDT - 7 weeks ago

Myomo Announces Participation in Upcoming Investor Conferences


Myomo Proxy statement: Proxy filing

May 14, 2026, 8:00 AM EDT - 7 weeks ago

Myomo Proxy statement: Proxy filing


Myomo Proxy statement: Proxy filing

May 14, 2026, 8:00 AM EDT - 7 weeks ago

Myomo Proxy statement: Proxy filing


Myomo Slides: Corporate presentation

May 14, 2026, 7:00 AM EDT - 7 weeks ago

Myomo Slides: Corporate presentation


Myomo Appoints Joseph M. Manko to its Board of Directors

May 13, 2026, 4:05 PM EDT - 7 weeks ago

Myomo Appoints Joseph M. Manko to its Board of Directors


Myomo reports Q1 EPS (7c), consensus (12c)

2026-05-07T22:43:59.000Z - 2 months ago

Myomo reports Q1 EPS (7c), consensus (12c)


Myomo sees Q2 revenue $10.3M-$10.8M, consensus $10.5M

2026-05-07T22:42:58.000Z - 2 months ago

Myomo sees Q2 revenue $10.3M-$10.8M, consensus $10.5M


Myomo Earnings Call Transcript: Q1 2026

May 7, 2026, 4:30 PM EDT - 2 months ago

Myomo Earnings Call Transcript: Q1 2026


Myomo Earnings release: Q1 2026

May 7, 2026, 4:30 PM EDT - 2 months ago

Myomo Earnings release: Q1 2026


Myomo Quarterly report: Q1 2026

May 7, 2026, 4:30 PM EDT - 2 months ago

Myomo Quarterly report: Q1 2026


Myomo Shareholder letter: Q1 2026

May 7, 2026, 4:30 PM EDT - 2 months ago

Myomo Shareholder letter: Q1 2026


Myomo announce availability of MyoPro at Ottobock Care Clinics

2026-05-04T20:12:26.000Z - 2 months ago

Myomo announce availability of MyoPro at Ottobock Care Clinics


Myomo Proxy statement: Proxy filing

May 4, 2026, 8:00 AM EDT - 2 months ago

Myomo Proxy statement: Proxy filing


Myomo to Report First Quarter 2026 Financial Results on May 7

May 1, 2026, 4:05 PM EDT - 2 months ago

Myomo to Report First Quarter 2026 Financial Results on May 7


Myomo launches Myomo Mobile App

2026-04-20T20:10:31.000Z - 2 months ago

Myomo launches Myomo Mobile App


Myomo Appoints William J Febbo to its Board of Directors

Apr 16, 2026, 4:05 PM EDT - 2 months ago

Myomo Appoints William J Febbo to its Board of Directors


Myomo Slides: Investor presentation

Apr 1, 2026, 7:00 AM EDT - 3 months ago

Myomo Slides: Investor presentation


Myomo price target lowered to $3 from $4 at Alliance Global

2026-03-12T11:11:26.000Z - 4 months ago

Myomo price target lowered to $3 from $4 at Alliance Global


Myomo Earnings Call Transcript: Q4 2025

Mar 9, 2026, 4:30 PM EDT - 4 months ago

Myomo Earnings Call Transcript: Q4 2025


Myomo Annual report: Q4 2025

Mar 9, 2026, 4:30 PM EDT - 4 months ago

Myomo Annual report: Q4 2025


Myomo Earnings release: Q4 2025

Mar 9, 2026, 4:30 PM EDT - 4 months ago

Myomo Earnings release: Q4 2025


Myomo sees FY26 revenue $43M-$46M, consensus $46.97M

2026-03-09T20:17:10.000Z - 4 months ago

Myomo sees FY26 revenue $43M-$46M, consensus $46.97M


Myomo sees Q1 revenue $9M-$9.5M, consensus $10.78M

2026-03-09T20:16:51.000Z - 4 months ago

Myomo sees Q1 revenue $9M-$9.5M, consensus $10.78M


Myomo reports Q4 EPS (9c), consensus (9c)

2026-03-09T20:10:28.000Z - 4 months ago

Myomo reports Q4 EPS (9c), consensus (9c)


Myomo Earnings Call Transcript: Q3 2025

Nov 10, 2025, 4:30 PM EST - 8 months ago

Myomo Earnings Call Transcript: Q3 2025


Myomo Earnings release: Q3 2025

Nov 10, 2025, 4:30 PM EST - 8 months ago

Myomo Earnings release: Q3 2025


Myomo Quarterly report: Q3 2025

Nov 10, 2025, 4:30 PM EST - 8 months ago

Myomo Quarterly report: Q3 2025


Myomo reports Q3 EPS (9c) , consensus (11c)

2025-11-10T21:16:40.000Z - 8 months ago

Myomo reports Q3 EPS (9c) , consensus (11c)


Myomo backs FY25 revenue view of $40M-$42M, consensus $40.19M

2025-11-10T21:16:12.000Z - 8 months ago

Myomo backs FY25 revenue view of $40M-$42M, consensus $40.19M


Myomo Reports Third Quarter 2025 Financial and Operating Results

Nov 10, 2025, 4:05 PM EST - 8 months ago

Myomo Reports Third Quarter 2025 Financial and Operating Results


MYO Earnings: Guidance Cut Slams Myomo Stock

2025-08-13T01:02:00.000Z - 11 months ago

MYO Earnings: Guidance Cut Slams Myomo Stock


Myomo price target lowered to $5 from $9.50 at H.C. Wainwright

2025-08-12T10:21:01.000Z - 11 months ago

Myomo price target lowered to $5 from $9.50 at H.C. Wainwright


Myomo Earnings Call Transcript: Q2 2025

Aug 11, 2025, 4:30 PM EDT - 11 months ago

Myomo Earnings Call Transcript: Q2 2025


Myomo Earnings release: Q2 2025

Aug 11, 2025, 4:30 PM EDT - 11 months ago

Myomo Earnings release: Q2 2025


Myomo Quarterly report: Q2 2025

Aug 11, 2025, 4:30 PM EDT - 11 months ago

Myomo Quarterly report: Q2 2025


Myomo reports Q2 EPS (11c), consensus (11c)

2025-08-11T20:22:04.000Z - 11 months ago

Myomo reports Q2 EPS (11c), consensus (11c)


Myomo cuts FY25 revenue view to $40M-$42M from $50M-$53M

2025-08-11T20:21:50.000Z - 11 months ago

Myomo cuts FY25 revenue view to $40M-$42M from $50M-$53M


Myomo Reports Second Quarter 2025 Financial and Operating Results

Aug 11, 2025, 4:05 PM EDT - 11 months ago

Myomo Reports Second Quarter 2025 Financial and Operating Results


Myomo price target lowered to $8 from $10 at Craig-Hallum

2025-06-23T17:47:09.000Z - 1 year ago

Myomo price target lowered to $8 from $10 at Craig-Hallum


Myomo Transcript: Investor Day 2025

Jun 18, 2025, 10:00 AM EDT - 1 year ago

Myomo Transcript: Investor Day 2025


Myomo Slides: FY 2025

Jun 18, 2025, 10:00 AM EDT - 1 year ago

Myomo Slides: FY 2025


Myomo price target lowered to $10 from $11 at Craig-Hallum

2025-05-08T13:39:13.000Z - 1 year ago

Myomo price target lowered to $10 from $11 at Craig-Hallum


Myomo Earnings Call Transcript: Q1 2025

May 7, 2025, 4:30 PM EDT - 1 year ago

Myomo Earnings Call Transcript: Q1 2025


Myomo Quarterly report: Q1 2025

May 7, 2025, 4:30 PM EDT - 1 year ago

Myomo Quarterly report: Q1 2025


Myomo Earnings release: Q1 2025

May 7, 2025, 4:30 PM EDT - 1 year ago

Myomo Earnings release: Q1 2025


Myomo to Host Investor & Analyst Day Event on June 18, 2025

May 1, 2025, 8:30 AM EDT - 1 year ago

Myomo to Host Investor & Analyst Day Event on June 18, 2025


Myomo to Report First Quarter 2025 Financial Results on May 7

Apr 30, 2025, 4:05 PM EDT - 1 year ago

Myomo to Report First Quarter 2025 Financial Results on May 7


Myomo Launches the MyoPro® 2x

Apr 30, 2025, 8:05 AM EDT - 1 year ago

Myomo Launches the MyoPro® 2x


Myomo Proxy statement: Proxy Filing

Apr 25, 2025, 8:00 AM EDT - 1 year ago

Myomo Proxy statement: Proxy Filing


Myomo Proxy statement: Proxy Filing

Apr 25, 2025, 8:00 AM EDT - 1 year ago

Myomo Proxy statement: Proxy Filing


Myomo Announces Upcoming Changes to its Board of Directors

Apr 10, 2025, 8:30 AM EDT - 1 year ago

Myomo Announces Upcoming Changes to its Board of Directors


Myomo Earnings Call Transcript: Q4 2024

Mar 10, 2025, 4:30 PM EDT - 1 year ago

Myomo Earnings Call Transcript: Q4 2024


Myomo Annual report: Q4 2024

Mar 10, 2025, 4:30 PM EDT - 1 year ago

Myomo Annual report: Q4 2024


Myomo Earnings release: Q4 2024

Mar 10, 2025, 4:30 PM EDT - 1 year ago

Myomo Earnings release: Q4 2024


Myomo Earnings Call Transcript: Q3 2024

Nov 6, 2024, 4:30 PM EST - 1 year ago

Myomo Earnings Call Transcript: Q3 2024


Myomo Quarterly report: Q3 2024

Nov 6, 2024, 4:30 PM EST - 1 year ago

Myomo Quarterly report: Q3 2024


Myomo Earnings release: Q3 2024

Nov 6, 2024, 4:30 PM EST - 1 year ago

Myomo Earnings release: Q3 2024


Myomo Registration statement: Registration Filing

Aug 26, 2024, 8:00 AM EDT - 2 years ago

Myomo Registration statement: Registration Filing


Myomo Earnings Call Transcript: Q2 2024

Aug 6, 2024, 4:30 PM EDT - 2 years ago

Myomo Earnings Call Transcript: Q2 2024


Myomo Quarterly report: Q2 2024

Aug 6, 2024, 4:30 PM EDT - 2 years ago

Myomo Quarterly report: Q2 2024


Myomo Earnings release: Q2 2024

Aug 6, 2024, 4:30 PM EDT - 2 years ago

Myomo Earnings release: Q2 2024


Myomo Slides: Q2 2024

Aug 6, 2024, 4:30 PM EDT - 2 years ago

Myomo Slides: Q2 2024


Myomo Reports Second Quarter 2024 Financial Results

Aug 6, 2024, 4:05 PM EDT - 2 years ago

Myomo Reports Second Quarter 2024 Financial Results


Myomo Registration statement: Registration Filing

Aug 6, 2024, 8:00 AM EDT - 2 years ago

Myomo Registration statement: Registration Filing


Myomo Transcript: Small-Cap Growth Virtual Investor Conference

Jun 12, 2024, 10:00 AM EDT - 2 years ago

Myomo Transcript: Small-Cap Growth Virtual Investor Conference


Myomo Earnings Call Transcript: Q1 2024

May 8, 2024, 4:30 PM EDT - 2 years ago

Myomo Earnings Call Transcript: Q1 2024


Myomo Quarterly report: Q1 2024

May 8, 2024, 4:30 PM EDT - 2 years ago

Myomo Quarterly report: Q1 2024


Myomo Earnings release: Q1 2024

May 8, 2024, 4:30 PM EDT - 2 years ago

Myomo Earnings release: Q1 2024


Myomo Slides: Q1 2024

May 8, 2024, 4:30 PM EDT - 2 years ago

Myomo Slides: Q1 2024


Myomo Reports First Quarter 2024 Financial Results

May 8, 2024, 4:05 PM EDT - 2 years ago

Myomo Reports First Quarter 2024 Financial Results


Myomo Proxy statement: Proxy Filing

Apr 26, 2024, 8:00 AM EDT - 2 years ago

Myomo Proxy statement: Proxy Filing


Myomo Proxy statement: Proxy Filing

Apr 26, 2024, 8:00 AM EDT - 2 years ago

Myomo Proxy statement: Proxy Filing


Myomo Appoints Heather Getz to its Board of Directors

Mar 28, 2024, 4:05 PM EDT - 2 years ago

Myomo Appoints Heather Getz to its Board of Directors


Myomo Earnings Call Transcript: Q4 2023

Mar 7, 2024, 4:30 PM EST - 2 years ago

Myomo Earnings Call Transcript: Q4 2023


Myomo Annual report: Q4 2023

Mar 7, 2024, 4:30 PM EST - 2 years ago

Myomo Annual report: Q4 2023


Myomo Earnings release: Q4 2023

Mar 7, 2024, 4:30 PM EST - 2 years ago

Myomo Earnings release: Q4 2023


Myomo Reports Preliminary Fourth Quarter Revenue and Backlog

Jan 17, 2024, 8:00 AM EST - 2 years ago

Myomo Reports Preliminary Fourth Quarter Revenue and Backlog


Myomo Earnings Call Transcript: Q3 2023

Nov 7, 2023, 4:30 PM EST - 2 years ago

Myomo Earnings Call Transcript: Q3 2023


Myomo Quarterly report: Q3 2023

Nov 7, 2023, 4:30 PM EST - 2 years ago

Myomo Quarterly report: Q3 2023


Myomo Earnings release: Q3 2023

Nov 7, 2023, 4:30 PM EST - 2 years ago

Myomo Earnings release: Q3 2023


2TrustHim
2TrustHim Jul. 4 at 2:15 PM
$MYO https://www.facebook.com/share/r/18nccoZfLV/?mibextid=wwXIfr
0 · Reply
R0tt3n
R0tt3n Jul. 4 at 4:41 AM
$MYO So, let me get this straight. He told you all to sell myo at .64 and buy Viking pharma at 34 bucks. Eventually Viking after dipping finally went to 39 bucks. Myo went to 1.54. And he’s claiming to have given sound advice like some genius? This is the height of idiocy. The math isn’t mathing with this guy.
0 · Reply
R0tt3n
R0tt3n Jul. 4 at 4:38 AM
$MYO that’s our resident Barry for ya.
0 · Reply
R0tt3n
R0tt3n Jul. 4 at 4:38 AM
$MYO fake n shake of the loose hands with coverage.
0 · Reply
jadeite_haystack
jadeite_haystack Jul. 2 at 8:58 PM
$MYO fake out then breakout. Back above $1.40
0 · Reply
iAccess_Alpha
iAccess_Alpha Jul. 2 at 3:52 PM
Missed it live? Access the $MYO presentation replay here: https://www.webcaster5.com/Webcast/Page/3165/54053 #microcap #smallcap #investing
0 · Reply
MultiversalTruth
MultiversalTruth Jul. 2 at 3:14 PM
$MYO AI QTRLY ANALYSIS - Updated Valuation Scenarios [Update your bull, base, and bear valuation scenarios and estimate: • Fair value • 12-month price target • Expected 52-week high • Expected 52-week low • Probability assigned to each scenario Tell me whether your conviction has increased, decreased, or stayed the same since the previous quarter, and explain why.] Bull Prob 30% Fair Val $9.50 Target $10–11 52H $12 52L $5.50 Base Prob 50% Fair Val $6.75 Target $7–8 52H $9 52L $4.50 Bear Prob 20% Fair Val $3.50 Target $3–4 52H $5 52L $2.25 Rationale The base case assumes: continued modest revenue growth,gross margins near 68%,improving operating leverage,and no significant equity dilution. The bull case depends on accelerating adoption through MyoConnect and stronger-than-expected reimbursement-driven growth leading toward sustained profitability.
1 · Reply
kurtb1969
kurtb1969 Jul. 2 at 1:33 PM
$MYO 970k shares now available for shorting, highest since October last year. Despite the negativity shorts are covering like crazy.
1 · Reply
kurtb1969
kurtb1969 Jul. 1 at 1:55 PM
$MYO massive short covering 777k shares available for shorting on IBKR by far the most available in over a month.
1 · Reply
Jedkra
Jedkra Jun. 30 at 7:39 PM
$MYO OmniHi5 is not a direct MyoPro replacement. It’s mainly a rehab/FES device, while MyoPro is a powered compensatory orthosis for daily use. Different category. Real competitors are more like HKK or Vincent, but Myomo still seems ahead in U.S. reimbursement and commercialization with HCPCS L8701/L8702 and Medicare reimbursement. MyoPro has real weaknesses: weight, comfort and patient selection. But saying it causes shoulder surgeries needs evidence, not just a bearish claim. Competition is real, but OmniHi5 is not the “MyoPro killer.” MYO’s bigger risks are execution, payer friction, cash burn and dilution.
1 · Reply
Aston_Martin007
Aston_Martin007 Jun. 30 at 5:35 PM
$MYO warning given over and over again
0 · Reply
Aston_Martin007
Aston_Martin007 Jun. 30 at 5:28 PM
$MYO i amply warned you any bounce is a trap. You had the chance to gtfo at 1.16 yesterday. I told you sell it and buy vktx. 12% swing in a single day. Did you do it? Kudos if you did. If youre holding this dead dawg dat don't hunt, than go to the nearest wall and hit your head on it repeatedly.
1 · Reply
Aston_Martin007
Aston_Martin007 Jun. 30 at 5:26 PM
$MYO sub $1 incoming!!! I told you
0 · Reply
kurtb1969
kurtb1969 Jun. 30 at 4:15 PM
$MYO Aston Martin is a genius he was short this stock at 62 cents and didn't cover, still down 64 percent after the expected down draft
0 · Reply
Aston_Martin007
Aston_Martin007 Jun. 30 at 3:26 PM
$MYO here i told you buy at 34 with a warning. 34-->41.23. Told you to sell myo 1.28-->1.03 But you doubted and now you are losing real money in 1 week. 100k in bktx netted you 21k. 100k in myo lost you 25k. Thats a 46k swing on a 100k investment!!! In 1 fucking week.
1 · Reply
Aston_Martin007
Aston_Martin007 Jun. 30 at 3:09 PM
0 · Reply
Aston_Martin007
Aston_Martin007 Jun. 30 at 3:04 PM
$MYO look at vktx sky rocket! You missed the fucking boat uf youre holding onto myo. The opportunity cost is so fucking huge. But you noobs will sell once it loses $1 and then this fucking thing is gonna lose its shit for good. Will be the last death cross and this company will be toast. Look at vktx shooting!!!
0 · Reply
Aston_Martin007
Aston_Martin007 Jun. 30 at 2:50 PM
$MYO had you listened and bought vktx and sold myo, you'd be up a net 10%! Had you done this 3 days ago you'd be up a net 35%! Listen noobies.
0 · Reply
fitchbuck
fitchbuck Jun. 30 at 2:47 PM
$MYO absolutely not true, there are now several other products in the market that are far lighter and cheaper, just look at the Omni Hi5 for one. The Myopro’s heft is injuring users to the point of needing shoulder surgery. Myomo’s time has come & gone. They blew their opportunity… and there is no road to recovery.
1 · Reply
2TrustHim
2TrustHim Jun. 30 at 2:42 PM
$MYO it’s kind of like the only assist available there isn’t that much competition correct
1 · Reply
Aston_Martin007
Aston_Martin007 Jun. 30 at 2:29 PM
$MYO yeah hard pass.
0 · Reply
Aston_Martin007
Aston_Martin007 Jun. 30 at 2:19 PM
$MYO i dare you nubiciles to buy this. Your glass is half full of shit if you think this is bullish. I wanna laugh to the bank. Rott3n currently in hiding as myo and xrp are both in the shitter battling for biggest loser. Warned on both but but but it's up so much from the bottom heh? Kurt1969 might be the dumbest dude on this board. Im so tired of him crying like a baby. Cmon noobs. If your bullish prove it show me your trades! Ive warned you of the fucking smackdown to your face and called wvwry freakijg move. Now youre scared cause you know this WILL go sub 1! 1.05 vs 1.04. Nice fucking picks! Gasp.
0 · Reply